当前位置:首页 - 行情中心 - 赛升药业(300485) - 财务分析

赛升药业

(300485)

  

流通市值:37.49亿  总市值:65.94亿
流通股本:2.74亿   总股本:4.82亿

赛升药业(300485)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.39亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益342426.00万元,未分配利润182335.02万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产358846.01万元,负债16420.01万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入92,536,534.42416,481,789.63322,881,323.81214,836,918.78
营业总成本90,214,129.14391,077,044.74304,126,046.59205,072,867.36
营业利润47,375,395.14-82,973,869.37-121,265,586.49-129,159,971.94
利润总额47,504,454.06-83,565,994.67-121,501,723.85-129,556,519.06
净利润38,944,931.94-76,874,137.69-102,205,314.55-108,262,333.29
其他综合收益-52,523.3537,717.47-382,426.79221,223.63
综合收益总额38,892,408.64-76,336,420.22-102,587,741.34-108,041,109.66
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,737,109,249.511,711,643,897.261,689,442,631.641,380,553,991.01
非流动资产合计1,851,350,806.551,840,204,668.211,828,337,816.352,123,110,163.97
资产总计3,588,460,056.063,551,848,565.473,517,780,447.993,503,664,154.98
流动负债合计73,656,476.4482,054,311.9683,109,768.0374,334,584.47
非流动负债合计90,543,615.5284,426,698.0580,254,445.6280,366,704.49
负债合计164,200,091.96166,481,010.01163,364,213.65154,701,288.96
归属于母公司股东权益合计3,397,029,455.233,357,111,952.593,326,846,743.433,320,498,226.71
股东权益合计3,424,259,964.13,385,367,555.463,354,416,234.343,348,962,866.02
负债和股东权益合计3,588,460,056.063,551,848,565.473,517,780,447.993,503,664,154.98
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计110,179,652.46447,810,497.61341,818,665.49225,629,269.5
经营活动现金流出小计99,495,887.84311,836,551.41236,357,427.7155,303,702.8
经营活动产生的现金流量净额10,683,764.62135,973,946.2105,461,237.7970,325,566.7
投资活动现金流入小计471,008,667.12749,432,232.48372,984,859.88281,399,737.66
投资活动现金流出小计497,572,256.83924,789,192.04479,406,883.9390,250,267.01
投资活动产生的现金流量净额-26,563,589.71-175,356,959.56-106,422,024.02-108,850,529.35
筹资活动现金流入小计-4,700,000--
筹资活动现金流出小计-10,587,354.3510,587,354.3510,587,354.35
筹资活动产生的现金流量净额--5,887,354.35-10,587,354.35-10,587,354.35
汇率变动对现金及现金等价物的影响-36,203.3368,603.89-261,946.79150,663.63
现金及现金等价物净增加额-15,916,028.39-44,901,763.82-11,810,087.37-48,961,653.37
期末现金及现金等价物余额59,346,661.9275,262,690.31108,354,366.7671,202,800.76
TOP↑